Jilin Aodong Pharmaceutical Group Co., Ltd. (SHE:000623)
China flag China · Delayed Price · Currency is CNY
16.84
+0.45 (2.75%)
Oct 30, 2026, 3:04 PM CST

SHE:000623 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
2,2382,3352,6113,4492,8682,304
Revenue Growth
-4.41%-10.55%-24.31%20.25%24.50%2.31%
Gross Profit
1,0191,0641,0081,6811,4511,193
Operating Income
-114.14-165.14-160.4134.53129.915.87
Net Income
2,9932,3951,5511,4601,7811,781
Earnings Per Share
2.552.041.321.231.471.51
EPS Growth
17.13%54.91%7.39%-16.35%-2.93%5.70%

Revenue by Segment

Fiscal Year
FY 2025
Period EndingDec '25
Group Investment Division
1.65
Medicine
1,798
Chain drugstore wholesale and retail
383.29
Food
199.7
Other Segment
140.82
Offset of Business Segment
-188.42
Total
2,335

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
3,0852,9632,6753,3783,8664,635
Total Debt
2,0952,2392,2893,0322,9902,616
Net Cash (Debt)
989.21724385.96346.02875.842,020
Net Cash Growth
14.71%87.58%11.54%-60.49%-56.63%-0.57%
Net Cash Per Share
0.840.620.330.270.671.60

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
308.59272.2659.4868.06423.86324.85
Capital Expenditures
-101.16-128.45-273.98-419.52-270.97-313.3
Free Cash Flow
207.42143.81-214.5-351.46152.8911.54
Free Cash Flow Growth
61.09%---1224.31%-92.92%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
45.52%45.58%38.62%48.74%50.59%51.76%
Operating Margin
-5.10%-7.07%-6.14%3.90%4.53%0.26%
Pretax Margin
129.79%103.66%58.28%43.49%60.00%76.69%
Profit Margin
133.71%102.57%59.43%42.33%62.09%77.29%
FCF Margin
9.27%6.16%-8.22%-10.19%5.33%0.50%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Dividend Per Share
0.5000.5000.5000.6000.3000.300
Dividend Per Share Growth
0%0%-16.67%100.00%0%50.00%
Dividend Yield
2.97%2.56%2.86%3.94%1.99%1.62%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
6.609.5613.3111.719.5611.81
Forward PE
-7.008.058.0224.0324.03
P/FCF Ratio
95.18159.22--111.321821.95
PS Ratio
8.829.817.914.965.939.13